In multivariate analysis, TP53 DBD missense mutations retained statistical significance as an independent PFS predictor (HR, 0.31; 95% CI, 0.13–0.77; p = 0.011, Table 3), together with tumor location and PTPRT/PTPRD deleterious alterations. Here, TP53 is linked to neoplasm.